 | Up a level |
Lee, Wen Shi 
ORCID: 0000-0001-7285-4054, Kristensen, Anne B., Rasmussen, Thomas A., Tolstrup, Martin ORCID: 0000-0001-7020-5173, Ostergaard, Lars ORCID: 0000-0002-7619-605X, Sogaard, Ole S., Wines, Bruce D., Hogarth, P. Mark, Reynaldi, Arnold ORCID: 0000-0002-5529-5542, Davenport, Miles P., Emery, Sean ORCID: 0000-0001-6072-8309, Amin, Janaki ORCID: 0000-0003-2161-9366, Cooper, David A., Kan, Virginia L., Fox, Julie, Gruell, Henning, Parsons, Matthew S. and Kent, Stephen J.
(2017).
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.
J. Virol., 91 (15).
WASHINGTON:
AMER SOC MICROBIOLOGY.
ISSN 1098-5514
Pett, Sarah Lilian, Amin, Janaki ORCID: 0000-0003-2161-9366, Horban, Andrejz, Andrade-Villanueva, Jaime, Losso, Marcelo, Porteiro, Norma, Sierra Madero, Juan, Belloso, Waldo, Tu, Elise, Silk, David, Kelleher, Anthony ORCID: 0000-0002-0009-3337, Harrigan, Richard, Clark, Andrew, Sugiura, Wataru, Wolff, Marcelo ORCID: 0000-0002-9956-8872, Gill, John, Gatell, Jose, Fisher, Martin, Clarke, Amanda, Ruxrungtham, Kiat, Prazuck, Thierry, Kaiser, Rolf, Woolley, Ian, Alberto Arnaiz, Juan, Cooper, David, Rockstroh, Jurgen K., Mallon, Patrick and Emery, Sean ORCID: 0000-0001-6072-8309
(2016).
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Clin. Infect. Dis., 63 (1).
S. 122 - 133.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1537-6591